CD40/CD40 ligand (CD40L) interaction plays an essential role in cell-mediated immune responses. We examined whether expression of CD40L in murine lung carcinoma (A11) cells could produce antitumor effects. The proliferation rate in vitro of A11 cells transfected with the murine CD40L gene (A11/CD40L) was not different from that of parent cells; however, half of the immunocompetent mice inoculated with A11/CD40L cells did not form tumors and the growth of A11/CD40L tumors developed in the rest of mice was significantly retarded compared with that of parent tumors. Protective immunity was also induced in the mice that had rejected A11/CD40L cells. In T-cell-defective nude mice, these antitumor effects were not observed. Bone-marrow-derived dendritic cells (DCs), when cultured with A11/CD40L cells, formed clusters with the tumors and showed upregulated CD86 expression. Expression of the interleukin-23 (IL-23) p19, IL-12p35, IL-18, interferon-g (IFN-g) and Mig (monokine induced by IFN-g) genes was induced in the DCs that were cultured with A11/CD40L but not with A11 cells, and P40, the subunit of both IL-12 and IL-23, was secreted from the cocultured DCs. These data directly showed that the expression of CD40L in tumors facilitated the interaction between DCs and the tumors, enhanced the maturation of DCs, induced secretion of cytokines, and consequently produced T-cell-dependent systemic immunity.
C D40 is a receptor of CD40 ligand (CD40L) and is expressed on antigen-presenting cells such as B cells and dendritic cells (DCs). CD40L is transiently expressed on activated CD4
+ T cells and the CD40/CD40L interaction triggers a number of events that are profoundly related with cardinal processes of antigen presentation; secretion of IL-12, 1 which can polarize immune responses to a T helper type 1 (Th1)-dominant state; production of proinflammatory cytokines; 2 and upregulation of costimulatory molecules such as CD86, which enhances cognate interactions between T and antigen-presenting cells.
3 CD40L whose expression is highly regulated thereby plays an essential role(s) in initiating immune responses. 4 Forced expression of CD40L on nonlymphoid could activate systemic immune responses and previous studies demonstrated that transfer of CD40L gene into solid tumors produced antitumor effects against the tumors.
5-7
Expressed CD40L on B-cell leukemia also induced antitumor activity and the strategy has been investigated for its clinical feasibility and effectiveness to treat chronic lymphocytic leukemia. 8 The mechanism of CD40L-mediated antitumor effects was suggested to be because of the activation of DCs and subsequent generation of cytotoxic T cells. [5] [6] [7] [8] Recent studies also showed that adenovirus-mediated transfer of the CD40L gene into DCs produced antitumor effects. 9, 10 However, the direct interaction between CD40L-expressed tumors and DCs has not been precisely analyzed. Inoculation of tumors alone may produce inflammatory cyotokines that activate DCs and transduction with empty adenovirus alone can activate DCs and enhance the antigen acquisition.
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In this study, we examined the antitumor effects of murine lung carcinoma A11 cells transduced with the CD40L gene and investigated the interaction between the CD40L-expressed tumors and bone marrow-derived DCs. We found that purified DCs were directly activated by the CD40L-expressed tumors and secreted a variety of cytokines including a novel cytokine interleukin-23 (IL-23), which enhances proliferation of memory T cells and production of IFN-g from activated T cells. 12 
Materials and methods

Cells and mice
High-metastatic A11 cells were established from Lewis lung carcinoma. 13 They were cultured in Dulbecco's modified Eagle's medium supplemented with 10% heatinactivated fetal calf serum. C57BL/6 and BALB/c nu/nu nude mice (6-to 8-week-old female) were purchased from Japan SLC (Hamamatsu, Japan).
Establishment of CD40L-expressed cells
A11 cells were transfected with the full-length mouse CD40L cDNA and then G418 (Life Technologies, Gaithersburg, MD) resistant cells were selected. They were examined for their expression of CD40L with flow cytometry. G418-resistant A11 cells transfected with vector DNA pMKITneo were used as a control.
Flow cytometry
Tumor cells were incubated with fluorescein-isothiocyanate (FITC)-conjugated anti-CD40L antibody (PharMingen, San Diego, CA) at room temperature for 20 minutes. Isotype-matched control antibody labeled with FITC was used for the background staining. Bone marrow-derived DCs were cultured with tumor cells that were labeled with PKH67 (Sigma, St Louis, MO) for 12 hours and then stained with phycoerythrin-conjugated anti-CD86 antibody (Caltag, Burlingame, CA). As a control, DCs were also incubated with 10 mg/ml lipopolysaccharide (LPS) for 12 hours. The stained cells were analyzed with FACScan (Becton Dickinson, Mountain View, CA) with CellQuest software (Becton Dickinson).
Animal experiments
Parent or transfected cells (2 Â 10 5 ) were subcutaneously inoculated into syngeneic or nude mice. Tumor volumes were calculated according to the formula, tumor volume ¼ 0.5 Â a Â b 2 , where a and b are the larger and the smaller diameter, respectively. For spontaneous lung metastasis, parent and transfected cells (2 Â 10 5 ) were subcutaneously injected into the abdominal flank of mice. The lungs were fixed with Bouin's solution and the number of metastatic nodules was counted on day 28. 13 Statistical analysis was performed by one-way analysis of variance (ANOVA). 
Preparation of DCs and culture with tumors
Bone marrow cells from tibias and femurs were depleted of erythrocytes with hypotonic buffer containing 0.15 M NH 4 Cl, 1 mM KHCO 3 , and 0.1 mM EDTA (pH 7.4). Macrophages, T and B cells were removed with biotinylated antibodies for CD4, CD8, B220, TER119, and CD11b, and streptavidin-conjugated magnetic beads. These cells were further incubated at 371C for 2 hours to remove adherent cells and then cultured in RPMI1640 medium supplemented with recombinant mouse GM-CSF and IL-4 (20 ng/ml each, PeproTech, London, UK), and 10% fetal calf serum for 10 days. Nonadherent cells were harvested and used as DCs. PKH67-labeled tumor cells 
Results
Expression of CD40L on A11 cells
Lewis lung carcinoma-derived A11 cells were transfected with the mouse CD40L gene and a clone expressing a large amount of CD40L on cell surface (A11/CD40L) was selected (Fig 1) . Expression of the class I antigens of the major histocompatibility complexes on A11 cells was undetectable with flow cytometry and was not upregulated after the forced expression of CD40L. The proliferation rate in vitro of A11/CD40L cells was not different from that of parent cells (data not shown).
Antitumor effects produced by A11/CD40L cells
We subcutaneously inoculated A11, A11/CD40L, or vector DNA-transfected A11 cells into immunocompetent syngeneic mice (Fig 2a) . All of the mice inoculated with parent and vector DNA-transfected A11 cells developed tumors and the growth in vivo was not different between the two groups. In contrast, seven out of 14 mice injected with A11/CD40L cells did not form tumors and the growth of A11/CD40L tumors developed in the rest of mice was significantly retarded compared with that of parent or vector DNA-transfected A11 tumors (Po.01, days 18, 21 and 24). All of the mice that had rejected A11/ CD40L cells were resistant to parent but not irrelevant tumors subsequently challenged (data not shown). When spleen cells of the mice that had rejected A11/CD40L cells were cultured with irradiated A11 cells, significant amounts of IFN-g were produced compared with naive mice (Table 1 ). The CD40L-mediated antitumor effects were also examined with the colony number of spontaneous lung metastasis (Table 2) . Subcutaneous inoculation of A11 cells produced metastatic foci in lung, but that of A11/CD40L cells formed few foci. When T-cell defective nude mice were inoculated with A11/CD40L cells, they developed tumors and the growth was not (Fig 2b) .
Interaction between DCs and A11/CD40L cells
We examined the effects of CD40L-expressed tumors on DCs. Bone marrow-derived DCs used in the present study showed an immature phenotype such as CD86 low . DCs were then cultured with either parent or A11/CD40L cells. We found that DCs formed more clusters with A11/ CD40L cells than with parent cells (Po.01, Fig 3a) and that expression level of CD86 was higher on DCs cultured with A11/CD40L cells than on those with parent cells (Fig  3b) . The upregulated level of CD86 expression on DCs cultured with A11/CD40L cells was almost equal to that on LPS-stimulated DCs (Fig 3b) . These data suggested that DCs maturated upon the coculture with A11/CD40L cells. There was no CD86 + PKH67 + cell population, implying that DCs did not phagocytose tumor cells.
Production of cytokines from DCs and tumors
We examined cytokine production induced by the DCstumor interaction. Since activated DCs secrete IL-12, 1 we measured the amounts of the P40 subunit in the supernatants of cultured cells (Fig 4a) . DCs cultured without tumor cells or those with parent tumors did not secrete P40. When DCs were cultured with A11/CD40L cells, DCs came to secrete a significant amount of P40. We also examined DCs that were cultured with A11 cells expressing Fas ligand (A11/FasL). Since bone marrow-derived DCs were positive for Fas and A11/FasL cells were rejected in the inoculated mice, 14 DCs cultured with A11/ FasL cells were comparable to those with A11/CD40L A novel cytokine IL-23 has been recently reported: it has heterodimeric structure composed of P19 subunit, which is a new molecule related to P35 of IL-12, and P40 subunit that is shared with IL-12.
12 Since DCs can secrete IL-23 as a P19/P40 heterodimer, 12 we examined the expression of the p19 and the p35 genes in the cultured cells. Both transcripts were detected from DCs cultured with A11/CD40L cells but not from others: DCs alone, tumor cells alone, or DCs cultured with parent or A11/ FasL cells (Fig 4b) . In order to quantitate the amounts of both transcripts, we performed PCR using serially diluted cDNA that were prepared from DCs cultured with A11/ CD40L cells (Fig 4c) . The signal intensity of the p19 product was greater than that of the p35 product in any of the diluted samples. We also examined the expression of other types of cytokine and chemokine that were related with differentiation and function of Th1 cells. Transcripts of IL-18, IFN-g, and Mig were detected from DCs cultured with A11/CD40L cells but not from the others (Fig 4b) . Neither IL-15 nor IL-21 transcript was detected in any of the cultured cell populations (data not shown).
Discussion
In this study, we showed that forced expression of the CD40L gene in tumor cells produced T-cell-dependent antitumor effects and induced protective immunity. Production of a significant amount of IFN-g from Allstimulated spleen cells of the mice that had rejected A11/ CD40L cells suggested the induction of cytotoxic T cells besides natural killer cells. Previous studies also showed that antitumor effects were achieved by the expression of CD40L on tumors [5] [6] [7] [8] and reported that the CD40L molecules could stimulate DCs through the CD40/ CD40L interaction. However, these studies did not directly demonstrate that the activation and the maturation of DCs were caused by the expressed CD40L on tumors. The present study revealed that bone marrowderived DCs tended to form clusters with A11/CD40L cells and that upregulated CD86 expression and cytokine production were induced by the interaction between DCs and CD40L-expressed tumors.
Since DCs were positive for Fas as well as CD40, we examined DCs cultured with A11/FasL cells. Our previous study showed that expression of FasL on All cells facilitated cluster formation between DCs and the tumors, and induced T-cell-mediated antitumor effects; 14 however, incubation with A11/FasL cells did not upregulate CD86 expression on DCs.
14 The present study also showed that the interaction between DCs and A11/FasL cells did not induce the expression of cytokine genes tested. The cluster formation thereby was not directly correlated with cytokine production or maturation of DCs. Although expression of these cytokines was detected from the mixture of DCs and the tumors, the transcripts should be derived from DCs. Since A11 cells were positive for both CD40 and Fas 13 and A11/CD40L and A11/FasL cells did not produce the cytokines, stimulation of A11/ CD40L and A11/FasL cells by the cocultured DCs could not induce cytokine production. The undetectable level of cytokine expression in DCs stimulated with A11/FasL cells was not because of the cell death of DCs, because DCs were resistant to apoptosis upon the Fas/FasL ligation despite their Fas expression. 15 DCs were in fact not apoptotic, when they were cultured with A11/FasL cells.
14 These data collectively suggested that interaction of immature DCs and FasL-expressed tumors could favor antigen presentation possibly through the cluster formation but did not induce maturation of DCs, whereas interaction of DCs and CD40L-expressed tumors did facilitate DCs maturation. We presume that maturation of DCs in the experiments of A11/FasL cells-mediated antitumor activity was induced by proinflammatory cytokines, which came to be produced by tumor inoculation in vivo.
Detection of P40 molecules in the culture supernatants and expression of both the IL-23p19 and the IL-12p35 transcripts suggested that both P35/P40 heterodimer (IL-12) and P19/P40 heterodimer (IL-23) were secreted from the DCs stimulated with A11/CD40L cells. The present data also implied that the amount of IL-23 was greater than that of IL-12; therefore, IL-23 as well as IL-12 could play a crucial role in DCs-T-cell interactions. DCs can potentially secrete IL-12, IL-18, IFN-g and Mig even in the resting state, [16] [17] [18] [19] however, CD40L-stimulated DCs have not been shown to increase the production of IFN-g and Mig. We speculate that DCs initially secrete IL-12 and IL-18, then IFN-g comes to be expressed by DCsderived IL-12 and/or IL-18 17 and Mig is induced by IFNg. 20 These cytokines can shift host immune responses to Th1-dominant state and Mig can attract activated T cells; 19 therefore, these soluble factors coordinately enhanced immune responses. IL-15, which augments immunostimuatory ability of DCs, 21 was not induced in the present study, although previous studies showed that IL-15 was secreted from CD40L-stimulated DCs. 18 IL-21, which can promote the activation of T and natural killer cells, 22, 23 was not induced. Both IL-15 and IL-21 may not be directly involved in the DCs-tumor cells interactions.
Expression of CD40L did not induce any biological changes in CD40-positive A11 cells such as cell adhesion, proliferation, and phosphorylation of intracellular protein. A recent study showed that CD40-expressed tumor cells could increase their tumor growth by impairing immune responses through the downregulation of CD40L on activated T cells. 24 In addition, A11 cells were less immunogenic because the class I expression on A11 cells was undetectable. However, forced expression of CD40L could induce systemic immunity against A11 by stimulating DCs. In conclusion, we examined the direct interaction between CD40L-expressed tumors and DCs, and observed the cluster formation between DCs and tumors, maturation of DCs and secretion cytokines from DCs. The interaction of CD40/CD40L facilitates antigen acquisition of DCs and these DCs are further stimulated by local production of Th1 cytokines; accordingly, generation of cytotoxic T cells is enhanced. Further investigation however is required as to whether DCs, cultured with A11 cells in the presence of CD40 agonist such as soluble CD40L, can augment acquisition of putative tumor antigens without the direct DCs-tumors interaction.
